St. Teresa Medical is a pioneering medical company based in Saint Paul, MN, dedicated to saving lives by developing innovative nanotechnology solutions to control bleeding. Their proprietary technology, FibriSEAL, utilizes electrospun dextran and human-derived proteins to create a revolutionary hemostatic dressing that does not swell in the body, making it highly effective in surgical procedures.
With their first product, SurgiCLOT, St. Teresa Medical introduces the world's first and only fibrin sealant designed specifically for bone bleeding. By delivering a bolus of human fibrinogen and thrombin through dextran nanofibers, SurgiCLOT promotes a fast, strong, and natural fibrin clot, aiding in the bone healing process. Although not yet cleared for use in the US or EU, St. Teresa Medical is at the forefront of developing cutting-edge solutions to address fluid loss and revolutionize the hemostatic and therapeutic markets.
Generated from the website